The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules


Here are the The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

Inflammatory bowel disease cks, the inflammatory response in stroke, icd 10 inflammatory bowel disease, inflammatory bowel disease diet, inflammatory bowel disease guidelines.

The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules

Inflammatory bowel disease (IBD) is a chronic or recurrent inflammatory disorder affecting various parts of the gastrointestinal tract. Metformin, a widely prescribed hypoglycemic drug for type 2 diabetes, has shown potential in reducing IBD risk. However, its oral administration faces significant challenges due to the harsh gastrointestinal environment, requiring higher or more frequent doses to achieve therapeutic effects, which increases the risk of side effects. To address this, we developed alginate-shelled hydrogel microcapsules with a thin oil layer for targeted intestinal delivery of metformin. The oil layer protects metformin from gastric acid and ensures its release specifically in the intestines. In a dextran sulfate sodium-induced colitis mouse model, metformin-loaded hydrogel microcapsules (MHM) significantly reduced disease activity, intestinal epithelial damage, and macrophage infiltration linked to pro-inflammatory cytokine factors. Additionally, MHM improved dysbiosis of specific bacterial genera, including Bacteroides vulgatus, Lactobacillus (L.) gasseri, L. reuteri, and L. intestinalis, optimizing the abundance and composition of microorganisms. These findings indicate that encapsulating metformin within alginate shelled-microcapsules with a thin oil layer presents a potential delivery system for IBD treatment. © 2024 Elsevier B.V.

Authors : Kim E.-J.; Jeong H.-S.; Park J.-Y.; Je J.-Y.; Choi C.-H.; Lee S.-J.

Source : Elsevier B.V.

Article Information

Year 2025
Type Article
DOI 10.1016/j.jconrel.2024.12.041
ISSN 01683659
Volume 378

You can download the article here


If You have any problem, contact us here


Support Us:

Download Now Buy me a coffee Request Paper Here